about
Decreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer.Effect of myeloid differentiation primary response gene 88 on expression profiles of genes during the development and progression of Helicobacter-induced gastric cancerDiagnostic Value of Combining Tumor and Inflammatory Markers in Lung Cancer.ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer.Association of sleep duration with apolipoproteins and the apolipoprotein B/A1 ratio: the China health and nutrition survey.The contemporary role and impact of urine-based biomarkers in bladder cancer.Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.Serum lipids and risk of obesity-related cancers in postmenopausal women.Blood lipid genetic scores, the HMGCR gene and cancer risk: a Mendelian randomization study.High scavenger receptor class B type I expression is related to tumor aggressiveness and poor prognosis in lung adenocarcinoma: A STROBE compliant article.Establishment and validation of a predictive nomogram model for non-small cell lung cancer patients with chronic hepatitis B viral infection.Preoperative serum apolipoprotein A-I levels predict long-term survival in non-muscle-invasive bladder cancer patients.Treating the Intestine with Oral ApoA-I Mimetic Tg6F Reduces Tumor Burden in Mouse Models of Metastatic Lung Cancer.Identification of serum proteins AHSG, FGA and APOA-I as diagnostic biomarkers for gastric cancer.Decreased pretherapy serum apolipoprotein A-I is associated with extent of metastasis and poor prognosis of non-small-cell lung cancerA Mendelian randomization study of the effects of blood lipids on breast cancer risk
P2860
Q33905987-09E59F6C-DDAF-4BB2-972C-9B28F286D6EAQ36281632-ACFAE9B2-20DB-41F8-BA4C-D06AFE785102Q37312934-854F1C49-67E0-4E18-8165-D78ABEACBA6CQ37390177-7939123B-F468-457A-9F2E-D14D49708819Q47193928-E5D88FB0-571B-43AB-A880-8891840C3A15Q47721208-FF9BF44E-67A6-4397-95B0-0C9D0FEFFE26Q49286468-D4285E69-2125-4D56-A261-D182AC6E7115Q49344024-C3FBCAFA-A05E-40C4-B983-0B9732540605Q49807681-68A37CB2-871B-40C8-90C2-040C2B8ACAA1Q53176614-4E6D4947-D31F-4547-A523-3CCCEFCDDE9FQ55027244-472D7A19-273B-46E8-A1C5-45E7B73A57DDQ55173600-21E00BA2-40C4-4ACA-81A4-BA3C9C5A7AEAQ55222132-AB82B469-682F-4045-A088-83D78EC40808Q55279779-5A8C67C6-4F7A-438B-A546-ADD5CA3A9E5AQ58565322-D429C9CB-0900-4178-A76B-6272C8EAA012Q59128982-036F57CC-68A4-4EAC-BFA2-D12D6DCA4627
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Apolipoproteins, lipids and risk of cancer.
@en
type
label
Apolipoproteins, lipids and risk of cancer.
@en
prefLabel
Apolipoproteins, lipids and risk of cancer.
@en
P2093
P2860
P50
P356
P1476
Apolipoproteins, lipids and risk of cancer.
@en
P2093
Dov Shiffman
Jonas Manjer
Peter Almgren
Talha Butt
Tanja Stocks
P2860
P304
P356
10.1002/IJC.30013
P577
2016-01-25T00:00:00Z